Poor drug safety controls may trigger another PPA scandal.

Published: 2005-04-21 06:55:00

Updated: 2005-04-21 06:55:00

Rep. Ahn Myeong-ok of the National Assembly, Health and Welfare Committee said in the KFDA report on April 19 that some drugs including levosulpiride that were not approved or prohibited to sell in the advanced countries such as the U. S. and Canada are commonly available in the Korean markets.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK